Cardiac fibrosis in oncologic therapies

RRS Packard - Current opinion in physiology, 2022 - Elsevier
Cardiotoxicity, or the development of unwarranted cardiovascular side-effects of oncologic
therapies, can involve all aspects of cardiovascular disease. The development of cardiac …
被引用次数：9 相关文章

Cardiac fibrosis in oncologic therapies.

RRS Packard - 2022 - escholarship.org
Cardiotoxicity, or the development of unwarranted cardiovascular side-effects of oncologic
therapies, can involve all aspects of cardiovascular disease. The development of cardiac …

Cardiac fibrosis in oncologic therapies

RRS Packard - Current opinion in physiology, 2022 - pubmed.ncbi.nlm.nih.gov
Cardiotoxicity, or the development of unwarranted cardiovascular side-effects of oncologic
therapies, can involve all aspects of cardiovascular disease. The development of cardiac …

Cardiac fibrosis in oncologic therapies.

RRS Packard - Current Opinion in Physiology, 2022 - europepmc.org
Cardiotoxicity, or the development of unwarranted cardiovascular side-effects of oncologic
therapies, can involve all aspects of cardiovascular disease. The development of cardiac …
[HTML] nih.gov

[HTML][HTML] Cardiac fibrosis in oncologic therapies

RRS Packard - Current opinion in physiology, 2022 - ncbi.nlm.nih.gov
Cardiotoxicity, or the development of unwarranted cardiovascular side-effects of oncologic
therapies, can involve all aspects of cardiovascular disease. The development of cardiac …

Cardiac fibrosis in oncologic therapies.

RRS Packard - Current Opinion in Physiology, 2022 - europepmc.org
Cardiotoxicity, or the development of unwarranted cardiovascular side-effects of oncologic
therapies, can involve all aspects of cardiovascular disease. The development of cardiac …